Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation.

@article{Zhu2010HigherSO,
  title={Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation.},
  author={Zhixiang Zhu and Quanbin Zhang and Lihong Chen and Shuang Ren and Ping-xiang Xu and Yu Tang and Dali Luo},
  journal={Thrombosis research},
  year={2010},
  volume={125 5},
  pages={
          419-26
        }
}
View on PubMed
doi.org
88 Citations
Highly Influential Citations
2
Background Citations
34
Methods Citations
3
Results Citations
2

88 Citations

Citation Type

Citation Type

A comparative study of antithrombotic and antiplatelet activities of different fucoidans from Laminaria japonica.
Study on antithrombotic and antiplatelet activities of low molecular weight fucoidan from Laminaria japonica
TLDR
Highly sulfated fucoidan LF2 with Mw 3900 seemed to be a more suitable choice for antithrombotic drug for its antithROMbotic activity accompanied with specific inhibitory activity on platelet aggregation, low anticoagulant activity and low hemorrhagic risk in vivo.
Modulation of platelet aggregation-related eicosanoid production by dietary F-fucoidan from brown alga Laminaria japonica in human subjects.
TLDR
The results suggested that dietary FD stimulated the expression of H2O2-producing enzymes in intestinal epithelial cells and released H2 O2 into the blood, which played a signalling role to increase PGI2 production and then shortened LT for thrombi.
The Antithrombotic Effects of Low Molecular Weight Fragment from Enzymatically Modified of Laminaria Japonica Polysaccharide
TLDR
LMWEP, an enzymatically modified fragment with a molecular weight of 25.8 kDa, is a potential antithrombotic candidate for treatment of thrombosis related diseases.
Antithrombotic activity of oral administered low molecular weight fucoidan from Laminaria Japonica.
Mechanism study of endothelial protection and inhibits platelet activation of low molecular weight fucoidan from Laminaria japonica
TLDR
By inhibiting platelet adhesion, LMW fucoidan played a role in anti-thrombosis and the specific mechanism of action is to inhibit the flow of extracellular Ca2+.
Algal fucoidan, unlike heparin, has thrombolytic activity in a murine arterial thrombosis model
TLDR
Algal fucoidan has both thrombolytic activity and a stimulatory effect on the thrombosynthetic activity of t-PA in a dose-dependent manner at an arterial thrombosis model.
A promising oral fucoidan-based antithrombotic nanosystem: Development, activity and safety.
TLDR
Surprisingly, oral antithrombotic profile of commercially available fucoidan, from Fucus vesiculosus, has not been previously determined, which reveals new possibilities in anticoagulant and antithROMbotic profiles offucoidan through the preparation of NpCF 1%.
A sulfated polysaccharide, fucans, isolated from brown algae Sargassum vulgare with anticoagulant, antithrombotic, antioxidant and anti-inflammatory effects.
Anti-Inflammatory Activity of Fucoidan Extracts In Vitro
TLDR
Fucoidan extracts from all species had significant anti-inflammatory effects, but the lowest molecular weight subfractions had maximal effects at low concentrations, which may offer insight into strategies that improve their efficacy against inflammation-related pathology.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 37 REFERENCES
Heparinoids algal and their anticoagulant, hemorrhagic activities and platelet aggregation.
Venous antithrombotic and anticoagulant activities of a fucoïdan fraction.
TLDR
Fucoïdan extracted from marine flora shows promise as an antithrombotic drug in rabbits and in a Wessler model of venous thrombosis.
Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro.
Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
TLDR
The results indicate that heparin cofactor II is activated by fucoidan in vitro and in an ex vivo plasma system and suggest that the major antithrombin activity of fucoidin in vivo is mediated by hepar in co Factor II and not by antithromabin III.
Effect of Low Molecular Weight Fucoidan and Low Molecular Weight Heparin in a Rabbit Model of Arterial Thrombosis
TLDR
LMWF appeared to be more effective thanLMWH for preventing arterial thrombosis in this experimental model and had a lower hemorrhagic risk than LMWH.
Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets.
Antithrombin-mediated Anticoagulant Activity of Sulfated Polysaccharides
TLDR
The conformational activation of antithrombin and the consequent formation of a covalent complex with thrombin appear to be less important for the anticoagulant activity of sulfated galactan than for heparin.
Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia
TLDR
LMW fucoidan potentiates FGF-2 activity, mobilizes SDF-1, and facilitates angiogenesis in a rat model, and could be of interest as an alternative for conventional treatment in critical ischemia.
Structure and Anticoagulant Activity of Sulfated Fucans
TLDR
The results indicate that different structural features determine not only the anticoagulant potency of the sulfated fucans but also the mechanism by which they exert this activity, and the branched fucan from brown algae are direct inhibitors of thrombin, whereas the linear fucANS from echinoderms require the presence of antithrombin or heparin cofactor II for inhibition ofThrombin.
...
1
2
3
4
...